Qiagen N.V. (LON: 0RLT)

Market Cap	8.53B
Revenue (ttm)	1.47B
Net Income (ttm)	69.34M
Shares Out	n/a
EPS (ttm)	0.31
PE Ratio	122.98
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	207,765
Average Volume	122,289
Open	45.58
Previous Close	45.39
Day's Range	45.58 - 46.05
52-Week Range	30.27 - 39.91
Beta	0.40
RSI	77.60
Earnings Date	Feb 3, 2025

About Qiagen

Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights. The company provides sample technology consumables, such as nucleic stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids from secondary sample materials; and instruments for n...

• Industry: Laboratory Analytical Instruments
• Founded: 1984
• Employees: 5,531
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RLT

Financial Performance

In 2023, Qiagen's revenue was $1.97 billion, a decrease of -8.23% compared to the previous year's $2.14 billion. Earnings were $341.30 million, a decrease of -19.35%.

Financial numbers in USD